Empagliflozin CAS: 864070-44-0 Chaw Tsim Khoom Siv

Empagliflozin yog ib yam tshuaj tshiab, muaj zog thiab xaiv tau SGLT-2 inhibitor, txhim kho kev tswj glycemic thiab cov yam ntxwv ntawm metabolic syndrome hauv cov nas uas muaj ntshav qab zib. Empagliflozin (lub npe lag luam Jardiance) yog ib yam tshuaj inhibitor ntawm sodium glucose co-transporter-2 (SGLT-2), thiab ua rau cov piam thaj hauv cov ntshav raug tso tawm los ntawm lub raum thiab tshem tawm hauv cov zis. Empagliflozin tuaj yeem ua rau lub cev qhuav dej thiab ua rau cov ntshav siab qis, ua rau cov neeg mob kiv taub hau lossis tsaus muag thiab ua haujlwm raum tsis zoo. Qhov kev pheej hmoo ntawm cov neeg mob laus, tshwj xeeb tshaj yog cov neeg uas muaj kev ua haujlwm raum tsis zoo thiab cov tshuaj diuretics, zoo li muaj ntau dua. FDA xav kom Boehring thiab Eli Lilly ua plaub qhov kev tshawb fawb tom qab kev lag luam: ua tiav kev sim tshuaj plawv, kev sim tshuaj pharmacokinetics thiab pharmacodynamics rau menyuam yaus, kev sim kev nyab xeeb thiab kev ua haujlwm ntawm menyuam yaus, kev sim tshuaj lom rau cov tshuaj (tshwj xeeb tshaj yog cov nyhuv rau kev ua haujlwm raum, pob txha thiab kev loj hlob thiab kev loj hlob).